Literature DB >> 2865677

Circadian variation in the frequency of onset of acute myocardial infarction.

J E Muller, P H Stone, Z G Turi, J D Rutherford, C A Czeisler, C Parker, W K Poole, E Passamani, R Roberts, T Robertson.   

Abstract

To determine whether the onset of myocardial infarction occurs randomly throughout the day, we analyzed the time of onset of pain in 2999 patients admitted with myocardial infarction. A marked circadian rhythm in the frequency of onset was detected, with a peak from 6 a.m. to noon (P less than 0.01). In 703 of the patients, the time of the first elevation in the plasma creatine kinase MB (CK-MB) level could be used to time the onset of myocardial infarction objectively. CK-MB-estimated timing confirmed the existence of a circadian rhythm, with a three-fold increase in the frequency of onset of myocardial infarction at peak (9 a.m.) as compared with trough (11 p.m.) periods. The circadian rhythm was not detected in patients receiving beta-adrenergic blocking agents before myocardial infarction but was present in those not receiving such therapy. If coronary arteries become vulnerable to occlusion when the intima covering an atherosclerotic plaque is disrupted, the circadian timing of myocardial infarction may result from a variation in the tendency to thrombosis. If the rhythmic processes that drive the circadian rhythm of myocardial-infarction onset can be identified, their modification may delay or prevent the occurrence of infarction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865677     DOI: 10.1056/NEJM198511213132103

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  312 in total

Review 1.  Pathogenesis and pathology of coronary heart disease syndromes.

Authors:  P M Ridker; E M Antman
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

2.  Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

3.  Current and Practical Management of Acute Myocardial Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

4.  Impaired beta-adrenoceptor mediated venodilation in patients with diabetes mellitus.

Authors:  K Harada; M Ohmori; Y Kitoh; K Sugimoto; A Fujimura
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

5.  Failure of magnesium to protect isolated cardiomyocytes from effects of hypoxia or metabolic poisoning.

Authors:  M M Gallagher; A P Allshire
Journal:  Clin Cardiol       Date:  2000-07       Impact factor: 2.882

Review 6.  Chronotherapeutics: are there meaningful differences among antihypertensive drugs?

Authors:  L Poirier; J Lefebvre; Y Lacourciere
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

Review 7.  Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure?

Authors:  A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1999-05       Impact factor: 4.335

8.  A percutaneous coronary intervention lab in every hospital?

Authors:  Thomas W Concannon; Jason Nelson; Jessica Goetz; John L Griffith
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-12-06

9.  Smad3 and Bmal1 regulate p21 and S100A4 expression in myocardial stromal fibroblasts via TNF-α.

Authors:  Fuyuki Sato; Akira Kohsaka; Kana Takahashi; Saki Otao; Yusuke Kitada; Yoshiyuki Iwasaki; Yasuteru Muragaki
Journal:  Histochem Cell Biol       Date:  2017-07-18       Impact factor: 4.304

Review 10.  Psychosocial stress and cardiovascular disease: pathophysiological links.

Authors:  C Noel Bairey Merz; James Dwyer; Cheryl K Nordstrom; Kenneth G Walton; John W Salerno; Robert H Schneider
Journal:  Behav Med       Date:  2002       Impact factor: 3.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.